Tempus AI (TEM) Stock Price, News & Analysis

Company Overview

Tempus AI is a technology company focused on applying data and artificial intelligence to healthcare, with an emphasis on precision medicine. Its platform combines clinical and molecular data to help physicians make more informed treatment decisions and support life-sciences research.

The company provides genomic sequencing and other diagnostic testing, software tools for analyzing patient data, and services that help identify clinical trial opportunities. Its work spans oncology and other areas of medicine, and it collaborates with healthcare providers and pharmaceutical and biotechnology companies.

Founded in 2015 by entrepreneur Eric Lefkofsky, Tempus is headquartered in Chicago. Lefkofsky serves as the company’s chief executive officer. Tempus primarily serves customers in the United States.

Key Stats

• Today's Range: $70.22 to $76.85
• 50-Day Range: $58.74 to $85.08
• 52-Week Range: $40.77 to $89.09
• Volume: 6.28 million shs
• Average Volume: 6.39 million shs
• Market Capitalization: $13.72 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $79.37
• Consensus Rating: Hold

Tempus AI Stock Analysis - MarketRank™

Tempus AI scored higher than 41% of companies evaluated by MarketBeat, and ranked 638th out of 886 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.6 / 5
• Analyst Rating: Hold

Consensus Rating

Tempus AI has received a consensus rating of Hold. The company's average rating score is 2.45, and is based on no strong buy ratings, 11 buy ratings, 10 hold ratings, and 1 sell rating.

Upside/Downside

The consensus price target for Tempus AI is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Tempus AI has been the subject of 15 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Tempus AI are expected to grow in the coming year, from ($1.20) to ($1.04) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Tempus AI is -71.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Tempus AI is -71.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Tempus AI has a P/B Ratio of 27.45. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

18.57% of the float of Tempus AI has been sold short.

Short Interest Ratio / Days to Cover

Tempus AI has a short interest ratio ("days to cover") of 3.55, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Tempus AI has recently increased by 1.02%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Tempus AI does not currently pay a dividend.

Dividend Growth

Tempus AI does not have a long track record of dividend growth.

News and Social Media

• Score: 3.5 / 5
• News Sentiment: 0.67

News Sentiment

Tempus AI has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 60 news articles for Tempus AI this week, compared to 10 articles on an average week.

Search Interest

Only 22 people have searched for TEM on MarketBeat in the last 30 days. This is a decrease of -63% compared to the previous 30 days.

MarketBeat Follows

31 people have added Tempus AI to their MarketBeat watchlist in the last 30 days. This is an increase of 244% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Tempus AI insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $85,388,983.00 in company stock.

Percentage Held by Insiders

24.26% of the stock of Tempus AI is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

24.22% of the stock of Tempus AI is held by institutions.

Company Calendar

• Last Earnings: 11/02/2026
• Today: 11/08/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:TEM
• Previous Symbol: NASDAQ:TEM
• CIK: 1717115
• Web: www.tempus.com
• Phone: 800-976-5448
• Fax: N/A
• Employees: 3,800
• Year Founded: 2015

Price Target and Rating

• Average Price Target for Tempus AI: $79.37
• High Price Target: $100.00
• Low Price Target: $50.00
• Potential Upside/Downside: +4.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.45
• Research Coverage: 22 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.06)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$245.03 million
• Net Margins: -12.54%
• Pretax Margin: -12.16%
• Return on Equity: -47.00%
• Return on Assets: -9.44%

Debt

• Debt-to-Equity Ratio: 2.70
• Current Ratio: 2.61
• Quick Ratio: 3.16

Sales & Book Value

• Annual Sales: $1.27 billion
• Price / Sales: 10.79
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.77 per share
• Price / Book: 27.45

Miscellaneous

• Outstanding Shares: 180,430,000
• Free Float: 136,661,000
• Market Cap: $13.72 billion
• Optionable: Optionable
• Beta: 3.61